The role of thrombolytic therapy in pregnant patients with prosthetic valve thrombosis

J Card Surg. 2022 Jun;37(6):1797-1798. doi: 10.1111/jocs.16467. Epub 2022 Mar 31.

Authors

Ahmet Güner¹, Cemalletin Akman¹, Kaan Gökçe¹, Ezgi G Güner¹, Macit Kalçık², Mehmet Ertürk¹

Affiliations

¹ Department of Cardiology, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
² Department of Cardiology, Faculty of Medicine, Hitit University, Corum, Turkey.

PMID: 35362195
DOI: 10.1111/jocs.16467

No abstract available

Publication types

Letter
Comment

MeSH terms

Female
Fibrinolytic Agents / therapeutic use
Heart Valve Diseases* / etiology
Heart Valve Prosthesis* / adverse effects
Humans
Pregnancy
Thrombolytic Therapy / adverse effects
Thrombosis* / chemically induced
Thrombosis* / etiology

Substances

Fibrinolytic Agents